BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1313452)

  • 1. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.
    Hung DT; Vu TK; Wheaton VI; Ishii K; Coughlin SR
    J Clin Invest; 1992 Apr; 89(4):1350-3. PubMed ID: 1313452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.
    Hung DT; Vu TK; Wheaton VI; Charo IF; Nelken NA; Esmon N; Esmon CT; Coughlin SR
    J Clin Invest; 1992 Feb; 89(2):444-50. PubMed ID: 1310695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domains specifying thrombin-receptor interaction.
    Vu TK; Wheaton VI; Hung DT; Charo I; Coughlin SR
    Nature; 1991 Oct; 353(6345):674-7. PubMed ID: 1717851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus.
    Brass LF; Vassallo RR; Belmonte E; Ahuja M; Cichowski K; Hoxie JA
    J Biol Chem; 1992 Jul; 267(20):13795-8. PubMed ID: 1321125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.
    Vu TK; Hung DT; Wheaton VI; Coughlin SR
    Cell; 1991 Mar; 64(6):1057-68. PubMed ID: 1672265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.
    Scarborough RM; Naughton MA; Teng W; Hung DT; Rose J; Vu TK; Wheaton VI; Turck CW; Coughlin SR
    J Biol Chem; 1992 Jul; 267(19):13146-9. PubMed ID: 1320011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual thrombin receptor system for platelet activation.
    Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
    Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor.
    Hung DT; Vu TH; Nelken NA; Coughlin SR
    J Cell Biol; 1992 Feb; 116(3):827-32. PubMed ID: 1309820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the protein C activation peptide with platelets.
    Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A
    Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate.
    Ishii K; Gerszten R; Zheng YW; Welsh JB; Turck CW; Coughlin SR
    J Biol Chem; 1995 Jul; 270(27):16435-40. PubMed ID: 7608215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High and moderate affinity pathways for alpha-thrombin-induced platelet activation.
    Greco NJ; Jamieson GA
    Proc Soc Exp Biol Med; 1991 Dec; 198(3):792-9. PubMed ID: 1658806
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide.
    Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA
    Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets.
    Jandrot-Perrus M; Huisse MG; Krstenansky JL; Bezeaud A; Guillin MC
    Thromb Haemost; 1991 Sep; 66(3):300-5. PubMed ID: 1746000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
    Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
    Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
    Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation.
    Bahou WF; Coller BS; Potter CL; Norton KJ; Kutok JL; Goligorsky MS
    J Clin Invest; 1993 Apr; 91(4):1405-13. PubMed ID: 8386186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.
    Gerszten RE; Chen J; Ishii M; Ishii K; Wang L; Nanevicz T; Turck CW; Vu TK; Coughlin SR
    Nature; 1994 Apr; 368(6472):648-51. PubMed ID: 8145852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
    Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
    Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor.
    Seiler SM; Goldenberg HJ; Michel IM; Hunt JT; Zavoico GB
    Biochem Biophys Res Commun; 1991 Dec; 181(2):636-43. PubMed ID: 1755847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.